Crestor and Body Odor
Body odor is not a recognized or documented adverse effect of Crestor (rosuvastatin) based on FDA labeling, comprehensive guidelines, or clinical trial data.
Evidence Review
After reviewing the FDA drug label 1, the 2013 Canadian Working Group consensus guideline on statin adverse effects 2, and multiple safety studies 3, 4, 5, 6, 7, 8, 9, body odor does not appear anywhere in the documented adverse effect profile of rosuvastatin.
Documented Adverse Effects of Rosuvastatin
The FDA label and clinical evidence identify these actual adverse effects:
Common side effects:
- Muscle pain, tenderness, or weakness (myopathy)
- Headache
- Nausea and abdominal pain
- Elevated liver enzymes
Dermatologic reactions documented:
Rare but serious effects:
- Rhabdomyolysis with potential kidney damage
- Hepatotoxicity
- Proteinuria and hematuria (particularly at higher doses) 9
Clinical Interpretation
If a patient reports body odor while taking Crestor, consider these alternative explanations:
- Coincidental timing - The symptom may be unrelated to the medication
- Dietary changes - Patients often modify their diet when starting cholesterol therapy, which can affect body odor
- Other medications - Review all concurrent medications for potential causes
- Underlying medical conditions - Metabolic disorders, infections, or other conditions may be responsible
- Hygiene-related factors - Unrelated personal factors
Recommendation
Do not discontinue rosuvastatin based on body odor complaints alone, as this symptom lacks any established causal relationship with the medication. The cardiovascular benefits of statin therapy in appropriate patients significantly outweigh concerns about this undocumented effect 8.
If the patient insists the symptom is medication-related and it significantly impacts quality of life, consider switching to an alternative statin (atorvastatin, simvastatin, pravastatin) to address patient concerns, though there is no pharmacologic rationale suggesting this would resolve the issue.
Document the complaint but investigate other potential causes before attributing it to rosuvastatin.